These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 31707376
1. Sotalol as an effective adjunct therapy in the management of supraventricular tachycardia induced fetal hydrops fetalis. Refaat M, El Dick J, Sabra M, Bitar F, Tayeh C, Abutaqa M, Arabi M. J Neonatal Perinatal Med; 2020; 13(2):267-273. PubMed ID: 31707376 [Abstract] [Full Text] [Related]
2. Prenatal management with digoxin and sotalol combination for fetal supraventricular tachycardia: case report and review of literature. Suri V, Keepanaseril A, Aggarwal N, Vijayvergiya R. Indian J Med Sci; 2009 Sep; 63(9):411-4. PubMed ID: 19805921 [Abstract] [Full Text] [Related]
3. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up. van der Heijden LB, Oudijk MA, Manten GT, ter Heide H, Pistorius L, Freund MW. Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470 [Abstract] [Full Text] [Related]
4. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias. Shah A, Moon-Grady A, Bhogal N, Collins KK, Tacy T, Brook M, Hornberger LK. Am J Cardiol; 2012 Jun 01; 109(11):1614-8. PubMed ID: 22444730 [Abstract] [Full Text] [Related]
5. Can digoxin and sotalol therapy for fetal supraventricular tachycardia and hydrops be successful? A case report. Merriman JB, Gonzalez JM, Rychik J, Ural SH. J Reprod Med; 2008 May 01; 53(5):357-9. PubMed ID: 18567282 [Abstract] [Full Text] [Related]
6. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, McCrindle BW, Ryan G, Manlhiot C, Blom NA. Circulation; 2011 Oct 18; 124(16):1747-54. PubMed ID: 21931080 [Abstract] [Full Text] [Related]
7. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases]. Jouannic JM, Delahaye S, Le Bidois J, Fermont L, Villain E, Dommergues M, Dumez Y. J Gynecol Obstet Biol Reprod (Paris); 2003 Jun 18; 32(4):338-44. PubMed ID: 12843882 [Abstract] [Full Text] [Related]
8. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology]. Azancot-Benisty A, Areias JC, Oberhänsli I, Schmidt KG, Tulzer G, Viart P. Arch Mal Coeur Vaiss; 1997 May 18; 90(5):735-43. PubMed ID: 9295960 [No Abstract] [Full Text] [Related]
9. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum. Agarwal A, Saha SC, Kaur A, Naganur S. BMJ Case Rep; 2023 Dec 28; 16(12):. PubMed ID: 38154874 [Abstract] [Full Text] [Related]
10. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy. Parilla BV, Strasburger JF, Socol ML. Am J Perinatol; 1996 Nov 28; 13(8):483-6. PubMed ID: 8989479 [Abstract] [Full Text] [Related]
12. [Flecaine: drug of choice for supraventricular tachycardias with anasarca. A case report]. Hamel P, Febbraro W, Barjot P, Lindet Y, Muller G, Iselin M. J Gynecol Obstet Biol Reprod (Paris); 1997 Nov 28; 26(1):37-9. PubMed ID: 9091542 [Abstract] [Full Text] [Related]
13. Flecainide against fetal supraventricular tachycardia complicated by hydrops fetalis. Barjot P, Hamel P, Calmelet P, Maragnes P, Herlicoviez M. Acta Obstet Gynecol Scand; 1998 Mar 28; 77(3):353-8. PubMed ID: 9539287 [No Abstract] [Full Text] [Related]
14. Complete resolution of arrhythmia-induced hydrops fetalis in utero. Narayanan M, Dhuka S, Alapati S, Kauffman RP. BMJ Case Rep; 2020 Oct 10; 13(10):. PubMed ID: 33040036 [Abstract] [Full Text] [Related]
15. Amiodarone in treatment of fetal supraventricular tachycardia. A case report and review of literature. Pradhan M, Manisha M, Singh R, Kapoor A. Fetal Diagn Ther; 2006 Oct 10; 21(1):72-6. PubMed ID: 16354980 [Abstract] [Full Text] [Related]
16. Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review. Tunca Sahin G, Beattie RB, Uzun O. Cardiol Young; 2022 Jul 10; 32(7):1077-1084. PubMed ID: 34551832 [Abstract] [Full Text] [Related]
17. Transplacental flecainide therapy for fetal supraventricular tachycardia in a twin pregnancy. Edwards A, Peek MJ, Curren J. Aust N Z J Obstet Gynaecol; 1999 Feb 10; 39(1):110-2. PubMed ID: 10099764 [Abstract] [Full Text] [Related]
18. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Uzun O, Babaoglu K, Sinha A, Massias S, Beattie B. Cardiol Young; 2012 Aug 10; 22(4):372-80. PubMed ID: 22008551 [Abstract] [Full Text] [Related]
19. Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience. O'Leary ET, Alexander ME, Bezzerides VJ, Drogosz M, Economy KE, Friedman KG, Pickard SS, Tworetzky W, Mah DY. J Cardiovasc Electrophysiol; 2020 May 10; 31(5):1105-1113. PubMed ID: 32100356 [Abstract] [Full Text] [Related]
20. Resolution of hydrops fetalis despite persistent fetal tachycardia. Silver LE, Platt LD, Santulli TV, Carlson DE. J Ultrasound Med; 2001 Oct 10; 20(10):1141-5. PubMed ID: 11587022 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]